Matthew Stanton, CHIEF SCIENTIFIC OFFICER at Generation Bio Co. (GBIO), sold 1,500 shares at $22.18 ($34K) on 2021-08-10, disclosed to the SEC on 2021-08-11.
Scheduled sale ($34k) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.18 | 1,000 | $22K | 65.3% |
| 2 | $23.36 | 400 | $9K | 27.5% |
| 3 | $24.19 | 100 | $2K | 7.1% |
| Total | $22.63 avg | 1,500 | $34K | 100% |
| Filing → |
| GBIO | SELL | 2021-08-25 | $38K | — | Filing → |
| GBIO | SELL | 2021-07-14 | $75K | — | Filing → |
| GBIO | SELL | 2021-06-17 | $42K | — | Filing → |